We are live on ! Find out more
RGEN icon

Repligen

442 hedge funds and large institutions have $7.33B invested in Repligen in 2025 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 172 increasing their positions, 130 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 45

32% more repeat investments, than reductions

Existing positions increased: 172 | Existing positions reduced: 130

3% more funds holding

Funds holding: 431442 (+11)

2.21% more ownership

Funds ownership: 100.37%102.58% (+2.2%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

9% less capital invested

Capital invested by funds: $8.09B → $7.33B (-$765M)

84% less call options, than puts

Call options by funds: $11M | Put options by funds: $68.6M

Holders
442
Holders Change
+11
Holders Change %
+2.55%
% of All Funds
5.92%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
60
Increased
172
Reduced
130
Closed
45
Calls
$11M
Puts
$68.6M
Net Calls
-$57.6M
Net Calls Change
-$22.2M

RGEN Hedge Fund Activity: Q1 2025 in Review

442 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q1 2025, worth a combined $7.33B — down 9.4% from $8.09B a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new RGEN positions and 45 closed out — a net gain of 15 holders — while 172 added to existing stakes and 130 trimmed.

The largest buyer was Invesco, adding an estimated $118M. The largest seller was Marshall Wace, cutting an estimated $50.4M.

  • 442 institutional investors held Repligen (RGEN) as of Q1 2025, up from 431 in Q4 2024.
  • Funds reported $7.33B of Repligen stock for Q1 2025, down 9.4% quarter-over-quarter.
  • 60 funds opened new Repligen positions in Q1 2025 and 45 closed out, a net change of +15 holders.
  • The largest Repligen buyer in Q1 2025 was Invesco, an estimated $118M added.
  • The largest Repligen seller in Q1 2025 was Marshall Wace, an estimated $50.4M sold.

Based on aggregated 13F filings for Q1 2025.